Eikonizo Therapeutics

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of brain-penetrant and peripherally-restricted small molecules designed to slow or modify the progression of neurodegenerative and cardiorenal diseases. Eikonizo Therapeutics is based in Cambridge, MA and was founded in 2017. It was valued at $54 million at its later-stage round in Dec 2023, the last priced event on record. It has raised $46.1 million across 2 recorded rounds; the latest was a $371,352 seed round in May 2018.

PMV mark · valuation
$54.0M
Oct 2026
Priced at
its later-stage round
Dec 2023
Total raised
$46.1M
Last round
Seed Round
May 2018
What is Eikonizo Therapeutics worth?
$54.0MPrivateMarketView mark · Oct 2026

Valued at $54.0M at its later-stage round, Dec 2023. Nothing has traded since.

Free account
More of Eikonizo Therapeutics with a free account
  • ·Watch Eikonizo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Eikonizo Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
May 2018Seed Round$371K▮
Mar 2018Seed Round$2.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Eikonizo Therapeutics valuation

Eikonizo Therapeutics was valued at $54 million at its later-stage round in Dec 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Eikonizo Therapeutics raised?

Eikonizo Therapeutics has raised $46.1 million in total; 2 of its rounds are on record. The largest on record was a $371,352 seed round in May 2018.

Eikonizo Therapeutics has filed 2 Form Ds with the SEC, most recently in May 2018 ($371,352 sold to 1 investor).

How Eikonizo Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Eikonizo Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Eikonizo Therapeutics

What is Eikonizo Therapeutics worth?
Eikonizo Therapeutics is valued at $54.0M as of Oct 2026. Valued at $54.0M at its later-stage round, Dec 2023. Nothing has traded since.
How much has Eikonizo Therapeutics raised?
Eikonizo Therapeutics has raised $46.1M in total funding across 2 recorded rounds.
When did Eikonizo Therapeutics last raise?
Eikonizo Therapeutics last raised in May 2018 (Seed Round), raising $371K.